[1]
|
UNAIDS (2018) Fact Sheet—Latest Statistics on the Status of the AIDS Epidemic. http://www.unaids.org/en/resources/fact-sheet
|
[2]
|
Porter, K., Gourlay, A., Attawell, K., Hales, D., Supervie, V., et al. (2018) Substantial Heterogeneity in Progress toward Reaching the 90-90-90 HIV Target in the WHO European Region. Journal of Acquired Immune Deficiency Syndromes, 79, 28-37. https://doi.org/10.1097/QAI.0000000000001761
|
[3]
|
European Centre for Disease Prevention and Control/WHO, Regional Office for Europe (2017) HIV/AIDS Surveillance in Europe 2017—2016 Data. ECDC, Stockholm.
|
[4]
|
Zheng, S. (2018) The Growing Threat of China’s HIV Epidemic. Lancet Public Health, 3, PE311. https://doi.org/10.1016/S2468-2667(18)30098-7
|
[5]
|
Robert-Koch-Institut (2017) Schätzung der Zahl der HIV-Neuinfektionen und der Gesamtzahl von Menschen mit HIV in Deutschland, Stand Ende 2016. Epidemiologisches Bulletin, 47, 535.
|
[6]
|
Dukhovlinova, E., Masharsky, A., Vasileva, A., Porrello, A., Zhou, S., Toussova, O., Verevochkin, S., Akulova, E., Frishman, D., Montefiori, D., Labranche, C., Hoffman, I., Miller, W., Cohen, M.S., Kozlov, A. and Swanstrom, R. (2018) Characterization of the Transmitted Virus in an Ongoing HIV-1 Epidemic Driven by Injecting Drug Use. AIDS Res Hum Retroviruses. https://doi.org/10.1089/aid.2017.0313
|
[7]
|
WHO (2011) Global Health Sector Strategy on HIV/AIDS 2011-2015. http://whqlibdoc.who.int/publications/2011/9789241501651_eng.pdf
|
[8]
|
Reeves, A., Steele, S., Stuckler, D., McKee, M., Amato-Gauci, A. and Semenza, J.C. (2017) Gender Violence, Poverty and HIV Infection Risk among Persons Engaged in the Sex Industry: Cross-National Analysis of the Political Economy of Sex Markets in 30 European and Central Asian Countries. HIV Medicine, 18, 748-755. https://doi.org/10.1111/hiv.12520
|
[9]
|
Behrends, C.N., Nugent, A.V., Des Jarlais, D.C., Frimpong, J.A., Perlman, D.C. and Schackman, B.R. (2018) Availability of HIV and HCV On-Site Testing and Treatment at Syringe Service Programs in the United States. Journal of Acquired Immune Deficiency Syndromes (Publish Ahead of Print).
|
[10]
|
Kariuki, S.M., Selhorst, Ph., Ariën, K.K. and Dorfmanet, J.R. (2017) The HIV-1 Transmission Bottleneck. Retrovirology, 14, 22. https://doi.org/10.1186/s12977-017-0343-8
|
[11]
|
Li, H., Bar, K.J., Wang, S., Decker, J.M., Chen, Y., et al. (2010) High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men. PLoS Pathogens, 6, e1000890. https://doi.org/10.1371/journal.ppat.1000890
|
[12]
|
Altice, F.L., Azbel, L., Stone, J., Brooks-Pollock, E., Smyrnov, P., Dvoriak, S., et al. (2016) The Perfect Storm: Incarceration and the High-Risk Environment Perpetuating Transmission of HIV, Hepatitis C Virus, and Tuberculosis in Eastern Europe and Central Asia. Lancet, 388, 1228-1248. https://doi.org/10.1016/S0140-6736(16)30856-X
|
[13]
|
ECDC (2017) HIV/AIDS Surveillance in Europe 2017-2016 Data. https://ecdc.europa.eu/en/publications-data/hivaids-surveillance-europe-2017-2016-data
|
[14]
|
Frieden, T., Das-Douglas, M., Kellerman, S.E. and Henning, K.J. (2005) Applying Public Health Principles to the HIV Epidemic. The New England Journal of Medicine, 353, 2397-2402. https://doi.org/10.1056/NEJMsb053133
|
[15]
|
Wu, Z., Tang, Z., Mao, Y., van Veldhuisen, P., Ling, W., Liu, D., Shen, Z., Detels, R., Lan, G., Erinoff, L., et al. (2017) Testing and Linkage to HIV Care in China: A Cluster-Randomised Trial. Lancet HIV, 4, e555-e565. https://doi.org/10.1016/S2352-3018(17)30131-5
|
[16]
|
Behrends, C.N., Nugent, A.V., Des Jarlais, D.C., Frimpong, J.A., David, C., Perlman, D.C. and Schackman, B.R. (2018) Availability of HIV and HCV On-Site Testing and Treatment at Syringe Service Programs in the United States. JAIDS Journal of Acquired Immune Deficiency Syndromes, 79, 1. https://doi.org/10.1097/QAI.0000000000001792
|
[17]
|
Wei, C.H. (2014) Strategies for Promoting HIV Testing Uptake: Willingness to Receive Couple-Based and Collective HIV Testing among a Cross-Sectional Online Sample of Men Who Have Sex with Men in China. Sexually Transmitted Infections, 90, 469-474. https://doi.org/10.1136/sextrans-2013-051460
|
[18]
|
ECDC (2017) ECDC and WHO Urge Improvement in Testing Practices. https://ecdc.europa.eu/en/publications-data/hivaids-surveillance-europe- 2017-2016-data https://ecdc.europa.eu/en/news-events/1-2-people-living-hiv-europe-diagnosed- late-ecdc-and-who-urgeimprovement-testing
|
[19]
|
Marcus, U., Nöstlinger, C., Rosińska, M., Sherriff, N., Gios, L., Dias, S.F., Gama, A.F., Toskin, I., Alexiev, I., Naseva, E., Schink, S.B., Mirandola, M. and the Sialon II Network (2018) Behavioural and Demographic Correlates of Undiagnosed HIV Infection in a MSM Sample Recruited in 13 European Cities. BMC Infectious Diseases, 18, 368. https://doi.org/10.1186/s12879-018-3249-8
|
[20]
|
European Centre for Disease Prevention and Control (ECDC) (2017) https://ecdc.europa.eu/en/news-events/ecdc-study-nearly-one-six-new-hiv-diagnoses -europe-are-among-people-over-50
|
[21]
|
Cheng, W.B., Tang, W.M., Han, Z.G., Tangthanasup, T.M., Zhong, F., Qin, F.J. and Xu, H.F. (2016) Late Presentation of HIV Infection: Prevalence, Trends, and the Role of HIV Testing Strategies in Guangzhou, China, 2008-2013. Journal of Biomedicine and Biotechnology, 2016, Article ID: 1631878. https://doi.org/10.1155/2016/1631878
|
[22]
|
Justice, A.C., et al. (2018) Clinical Presentation of HIV Differs by Age in VACS (2010-15). Conference on Retroviruses and Opportunistic Infections (CROI) 2018, Boston, 4-7 March 2018.
|
[23]
|
Hellmuth, J., Valcour, V. and Spudich, S. (2015) CNS Reservoirs for HIV: Implications for Eradication. Journal of Virus Eradication, 1, 67-71.
|
[24]
|
Sanford, R., Ances, B.M., Meyerhoff, D.J., Price, R.W., Fuchs, D., Zetterberg, H., Spudich, S. and Collins, D.L. (2018) Longitudinal Trajectories of Brain Volume and Cortical Thickness in Treated and Untreated Primary Human Immunodeficiency Virus Infection. Clinical Infectious Diseases, ciy362. https://doi.org/10.1093/cid/ciy362
|
[25]
|
Eggers, C., Arendt, G., Hahn, K., Husstedt, I.W., Maschke, M., Neuen-Jacob, E., Obermann, M., Rosenkranz, T., Schielke, E., Straube, E. and German Association of Neuro-AIDS und Neuro-Infectiology (DGNANI) (2017) HIV-1-Associated Neurocognitive Disorder: Epidemiology, Pathogenesis, Diagnosis, and Treatment. Journal of Neurology, 264, 1715-1727. https://doi.org/10.1007/s00415-017-8503-2
|
[26]
|
Carroll, A. and Brew, B. (2017) HIV-Associated Neurocognitive Disorders: Recent Advances in Pathogenesis, Biomarkers, and Treatment. F1000Research, 6, 312. https://doi.org/10.12688/f1000research.10651.1
|
[27]
|
HIV.gov. (2017) Aging with HIV. https://www.hiv.gov/hiv-basics/living-well-with-hiv/taking-care-ofyourself/aging-with-hiv
|
[28]
|
Kusejko, K., Marzel, A., Hampel, B., Bachmann, N., Nguyen, H., Fehr, J., et al. and Swiss HIV Cohort Study (2018) Quantifying the Drivers of HIV Transmission and Prevention in Men Who Have Sex with Men: A Population Model-Based Analysis in Switzerland. HIV Medicine, 26, 1-10. https://doi.org/10.1111/hiv.12660
|
[29]
|
Grossmann, I., Rockstroh, J.K., Schwarze-Zander, C., Boesecke, C. and Wasmuth, J.C. (2017) Ursache und Blipps unter laufender antiretroviraler Therapie. (Translation by the author (RHD): Cause and Blips with Ongoing Antiretroviral Therapy.) Deutsch-Österreichischer AIDS-Kongress (DÖAK), Salzburg, Poster 21, Abstract ID: 060.
|
[30]
|
Colby, D.J., Trautmann, L., Pinyakorn, S., Leyre, L., Pagliuzza, A., et al. (2018) Rapid HIV RNA Rebound after Antiretroviral Treatment Interruption in Persons Durably Suppressed in Fiebig I Acute HIV Infection. Nature Medicine, 24, 923-926. https://doi.org/10.1038/s41591-018-0026-6
|
[31]
|
Hermans, L., Moorhouse, M., Carmona, S. and Wensing, A.M.J. (2018) Effect of HIV-1 Low-Level Viraemia during Antiretroviral Therapy on Treatment Outcomes in WHO-Guided South African Treatment Programmes: A Multicentre Cohort Study. Lancet Infectious Diseases, 18, 188-197. https://doi.org/10.1016/S1473-3099(17)30681-3
|
[32]
|
Marukutira, T., Stoové, M., Lockman, S., Mills, L.A., Gaolathe, T., Lebelonyane, R., Jarvis, J.N., Kelly, S.L., Wilson, D.P., et al. (2018) A Tale of Two Countries: Progress towards UNAIDS 90-90-90 Targets in Botswana and Australia. Journal of the International AIDS Society, 21, e25090. https://doi.org/10.1002/jia2.25090
|
[33]
|
Pilcher, H. (2004) HIV Outpaces Global Response. UN Report Outlines the Spread of AIDS. Nature. https://www.nature.com/news/2004/040705/full/news040705-5.html
|
[34]
|
Flickinger, T.E., Berry, S., Korthuis, T., Saha, S., Laws, M.B, Sharp, V., Moore, R.D. and Beach, M.C. (2013) Counseling to Reduce High-Risk Sexual Behavior in HIV Care: A Multi-Center, Direct Observation Study. AIDS Patient Care and STDs, 27, 416-424. https://doi.org/10.1089/apc.2012.0426
|
[35]
|
Macapagal, K., Birkett, M., Janulis, P., Garofalo, R. and Mustanski, B. (2017) HIV Prevention Fatigue and HIV Treatment Optimism among Young Men Who Have Sex with Men. AIDS Education and Prevention, 29, 289-301. https://doi.org/10.1521/aeap.2017.29.4.289
|
[36]
|
Hess, K.L., Crepaz, N., Rose, C., Purcell, D. and Paz-Bailey, G. (2017) Trends in Sexual Behavior among Men Who Have Sex with Men (MSM) in High-Income Countries, 1990-2013: A Systematic Review. AIDS and Behavior, 21, 2811-2834. https://doi.org/10.1007/s10461-017-1799-1
|
[37]
|
Ostrow, D.E., Fox, K.J., Chmiel, J.S., Silvestre, A., Visscher, B.R., Vanable, P.A., Jacobson, L.P. and Strathdee, S.A. (2002) Attitudes towards Highly Active Antiretroviral Therapy Are Associated with Sexual Risk Taking among HIV Infected and Uninfected Homosexual Men. AIDS, 16, 775-780. https://doi.org/10.1097/00002030-200203290-00013
|
[38]
|
Warren, E.A., Paterson, P., Schulz, W.S., Lees, S., Eakle, R., Stadler, J., et al. (2018) Risk Perception and the Influence on Uptake and Use of Biomedical Prevention Interventions for HIV in Sub-Saharan Africa: A Systematic Literature Review. PLoS One, 13, e0198680. https://doi.org/10.1371/journal.pone.0198680
|
[39]
|
McNaghten, A.D., Kearns, R., Siegler, A.J., Phaswana-Mafuya, N., Bekker, L.G., Stephenson, R., Baral, S.D., Brookmeyer, R., Yah, C.S., et al. (2014) Sibanye Methods for Prevention Packages Program Project Protocol: Pilot Study of HIV Prevention Interventions for Men Who Have Sex with Men in South Africa. JMIR Research Protocols, 3, e55. https://doi.org/10.2196/resprot.3737
|
[40]
|
Basten, M., Heijne, J.C.M., Geskus, R., Den Daas, C., Kretzschmar, M. and Matser, A. (2018) Sexual Risk Behaviour Trajectories among MSM at Risk for HIV in Amsterdam, the Netherlands. AIDS, 32, 1185-1192. https://doi.org/10.1097/QAD.0000000000001803
|
[41]
|
Dangerfield, D.T., Carmack, C.C., Gilreath, T.D. and Duncan, D.T. (2018) Latent Classes of Sexual Positioning Practices and Sexual Risk among Men Who Have Sex with Men in Paris, France. AIDS and Behavior, 22, 4001-4008. https://doi.org/10.1007/s10461-018-2267-2
|
[42]
|
Pradat, P., Huleux Th., Raffi, F., et al. (2018) Incidence of New Hepatitis C Virus Infection Is Still Increasing in French MSM Living with HIV. AIDS, 32, 1077-1082. https://doi.org/10.1097/QAD.0000000000001789
|
[43]
|
Cuypers, L., Pérez, A.B., Chueca, N., Aldamiz-Echevarría, T., Alados, J.C., Martínez-Sapiña, A.M., et al. (2018) Relapse or Reinfection after Failing Hepatitis C Direct Acting Antiviral Treatment: Unravelled by Phylogenetic Analysis. PLoS ONE, 13, e0201268. https://doi.org/10.1371/journal.pone.0201268
|
[44]
|
Rhee, S.Y., Clutter, D., Fessel, W.J., Klein, D., Slome, S., Pinsky, B.A., et al. (2018) Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted HIV-1 Drug Resistance in a Large US Clinic Population. Clinical Infectious Diseases, ciy453 [Epub Ahead of Print]. https://doi.org/10.1093/cid/ciy453
|
[45]
|
Wang, X., Liu, X., Li, F., Zhou, H., Li, J., Wang, Y., Liu, L., Liu, S., Feng, Y., and Wang, N. (2018) Epidemiological Surveillance of HIV-1 Transmitted Drug Resistance among Newly Diagnosed Individuals in Shijiazhuang, Northern China, 2014-2015. PLoS One, 13, e0198005. https://doi.org/10.1371/journal.pone.0198005
|
[46]
|
Gupta, R.K., Gregson, J., Parkin, N., Haile-Selassie, H., Tanuri, A., Forero, L.A., Kaleebu, P., Watera, C., Aghokeng, A., Mutenda, N., et al. (2017) HIV-1 Drug Resistance before Initiation or Re-Initiation of First-Line Antiretroviral Therapy in Low-Income and Middle-Income Countries: A Systematic Review and Meta-Regression Analysis. The Lancet Infectious Diseases, 18, 346-355. https://doi.org/10.1016/S1473-3099(17)30702-8
|
[47]
|
Yerly, S. and Calmy, A. (2018) Time to Overcome Pretreatment HIV Drug Resistance. The Lancet Infectious Diseases, 18, 239-240. https://doi.org/10.1016/S1473-3099(17)30709-0
|
[48]
|
Beyrer, C. and Pozniak, A. (2017) HIV Drug Resistance—An Emerging Threat to Epidemic Control. The New England Journal of Medicine, 377, 1605-1607. https://doi.org/10.1056/NEJMp1710608
|
[49]
|
Barouch, D.H. (2018) A Step forward for HIV Vaccines. Lancet HIV, 5, 2338-e2339. https://doi.org/10.1016/S2352-3018(18)30095-X
|
[50]
|
Holt, M., Lea, T., Mao, L., Kolstee, J., Zablotska, I., Duck, T., Allan, B., West, M., Lee, E., Hull, P., Grulich, A., De Wit, J. and Prestage, G. (2018) Community-Level Changes in Condom Use and Uptake of HIV Pre-Exposure Prophylaxis by Gay and Bisexual Men in Melbourne and Sydney, Australia: Results of Repeated Behavioural Surveillance in 2013-17. Lancet HIV, 5, e448-e456. https://doi.org/10.1016/S2352-3018(18)30072-9
|
[51]
|
The Antiretroviral Therapy Cohort Collaboration (2017) Survival of HIV-Positive Patients Starting Antiretroviral Therapy between 1996 and 2013: A Collaborative Analysis of Cohort Studies. Lancet HIV, 4, e349-e356. https://doi.org/10.1016/S2352-3018(17)30066-8
|
[52]
|
Riddell, J., Amico, K.R. and Mayer, K.H. (2018) HIV Preexposure Prophylaxis: A Review. JAMA, 319, 1261-1268. https://doi.org/10.1001/jama.2018.1917
|
[53]
|
Traeger, M.W., Schroeder, S.E., Wright, E.J., Hellard, M.E., Cornelisse, V.J., Doyle, J.S. and Stoové, M.A. (2018) Effects of Pre-Exposure Prophylaxis for the Prevention of Human Immunodeficiency Virus Infection on Sexual Risk Behaviour in Men Who Have Sex with Men: A Systematic Review and Meta-Analysis. Clinical Infectious Diseases, 67, 676-686. https://doi.org/10.1093/cid/ciy182
|
[54]
|
Moazen, B., Saeedi Moghaddam, S., Silbernagl, M.A., Lotfizadeh, M., Bosworth, R.J., Alammehrjerdi, Z., Kinner, S.A., Wirtz, A.L., Bärnighausen, T.W., Stöver, H.J. and Dolan, K.A. (2018) Prevalence of Drug Injection, Sexual Activity, Tattooing, and Piercing Among Prison Inmates. Epidemiologic Reviews, 40, 58-69. https://doi.org/10.1093/epirev/mxy002
|
[55]
|
Halkitis, P.N. and Parsons, J.T. (2003) Intentional Unsafe Ex (Barebacking) among HIV-Positive Gay Men Who Seek Sexual Partners on the Internet. Aids Care, 15, 367-78. https://doi.org/10.1080/0954012031000105423
|
[56]
|
(2018) 2nd European ChemSex Forum, Berlin, 22-24 March 2018. https://idpc.net/events/2018/03/2ndeuropean-chemsex-forum
|
[57]
|
Pufall, E.L., Kall, M., Shahmanesh, M., Nardone, A., Gilson, R., Delpech, V. and Ward, H. and Positive Voices Study Group (2018) Sexualized Drug Use (“Chemsex”) and High-Risk Sexual Behaviours in HIV-Positive Men Who Have Sex with Men. HIV Medicine, 19, 261-270. https://doi.org/10.1111/hiv.12574
|
[58]
|
González-Baeza, A., Dolengevich-Segal, H., Pérez-Valero, I., Cabello, A., Téllez, M.J., Sanz, J., Pérez-Latorre, L., Bernardino, J.I., Troya, J., De La Fuente, S., et al. (2018) Sexualized Drug Use (Chemsex) Is Associated with High-Risk Sexual Behaviors and Sexually Transmitted Infections in HIV-Positive Men Who Have Sex with Men: Data from the U-SEX GESIDA 9416 Study. AIDS Patient Care and STDs, 32, 112-118. https://doi.org/10.1089/apc.2017.0263
|
[59]
|
Sewella, J., Miltza, A., Lampea, F.C., Cambianoa, V., Speakmana, A., Phillipsa, A.N., Stuart, D., Gilsona, R., Asboeb, D., Nwokolob, N., Clarkec, A., Collinsd, S., Harta, G., Elforde, J., Rodgera, A.J. and the Attitudes to and Understanding of Risk of Acquisition of HIV (AURAH) Study Group (2017) Poly Drug Use, Chemsex Drug Use, and Associations with Sexual Risk Behaviour in HIV-Negative Men Who Have Sex with Men Attending Sexual Health Clinics. International Journal of Drug Policy, 43, 33-43. https://doi.org/10.1016/j.drugpo.2017.01.001
|
[60]
|
Pakianathan, M., Whittaker, W., Lee, M.J., Avery, J., Green, S., Nathan, B. and Hegazi, A. (2018) Chemsex and New HIV Diagnosis in Gay, Bisexual and Other Men Who Have Sex with Men Attending Sexual Health Clinics. HIV Medicine.
|
[61]
|
Halkitis, P.N., Parsons, J.T. and Stirratt, M.J. (2001) A Double Epidemic: Crystal Methamphetamine Drug Use in Relation to HIV Transmission among Gay Men. Journal of Homosexuality, 41, 17-35. https://doi.org/10.1300/J082v41n02_02
|
[62]
|
Ward, C., McQuillan, O. and Evans, R. (2018) Chemsex, Consent and the Rise in Sexual Assault. Oral Presentation, O14. Chemsex Forum, Berlin. https://sti.bmj.com/content/sextrans/93/Suppl_1/A5.2.full.pdf
|
[63]
|
van de Laar, T.J. and Richel, O. (2017) Emerging Viral STIs among HIV-Positive Men Who Have Sex with Men: The Era of Hepatitis C Virus and Human Papillomavirus. Sexually Transmitted Infections, 93, 368-373. https://doi.org/10.1136/sextrans-2016-052677
|
[64]
|
Combes, J.D., Heard, I., Poizot-Martin, I., Canestri, A., Lion, A., Piroth, L., Didelot, J.M., Ferry, T., Patey, O., Marchand, L., et al. and ANRS EP57 APACHES Study Group (2018) Prevalence and Risk Factors for Anal Human Papillomavirus Infection in Human Immunodeficiency Virus-Positive Men Who Have Sex with Men. Journal of Infectious Diseases, 217, 1535-1543. https://doi.org/10.1093/infdis/jiy059
|
[65]
|
Nikolopoulos, G.K., Kostaki, E.G. and Paraskevis, D. (2016) Overview of HIV Molecular Epidemiology among People Who Inject Drugs in Europe and Asia. Infection, Genetics and Evolution, 46, 256-268. https://doi.org/10.1016/j.meegid.2016.06.017
|
[66]
|
Verhofstede, Ch., Dauwe, K., Fransen, K., Van Laethem, K., Van den Wijngaert, S., Ruelle, J., et al. (2018) Phylogenetic Analysis of the Belgian HIV-1 Epidemic Reveals that Local Transmission Is Almost Exclusively Driven by Men Having Sex with Men Despite Presence of Large African Migrant Communities. Infection, Genetics and Evolution, 61, 36-44. https://doi.org/10.1016/j.meegid.2018.03.002
|
[67]
|
Race, K. (2015) “Party and Play”: Online Hook-Up Devices and the Emergence of PNP Practices among Gay Men. Sexualities, 18, 253-275. https://doi.org/10.1177/1363460714550913
|
[68]
|
Klein, H. (2009) Sexual Orientation, Drug Use Preference during Sex, and HIV Risk Practices and Preferences among Men Who Specifically Seek Unprotected Sex Partners via the Internet. International Journal of Environmental Research Public Health, 6, 1620-1635. https://doi.org/10.3390/ijerph6051620
|
[69]
|
Dustin, T., Duncan, D.T., Park, S.H., Hambrick, H.R., Dangerfield II, D.T., Goedel, W.C., et al. (2018) Characterizing Geosocial-Networking App Use Among Young Black Men Who Have Sex with Men: A Multi-City Survey in the Deep South (Preprint). JMIR Mhealth Uhealth, 6, e10316. https://doi.org/10.2196/10316
|
[70]
|
Zeng, H., Li, T., Wang, Y., Sun, B. and Yang, R. (2016) The Epidemic Dynamics of Four Major Lineages of HIV-1 CRF01_AE Strains After Their Introduction into China. AIDS Research and Human Retroviruses, 32, 420-426. https://doi.org/10.1089/aid.2015.0212
|
[71]
|
Wang, X., He, X., Zhong, P., Liu, Y., Gui, T., Jia, D., Li, H., Wu, J., Yan, J., Kang, D., et al. (2017) Phylodynamics of Major CRF01_AE Epidemic Clusters Circulating in Mainland of China. Scientific Reports, 7, 6330. https://doi.org/10.1038/s41598-017-06573-6
|
[72]
|
Takebe, Y., Liao, H., Hase, S., Uenishi, R., Li, Y., Li, X.J., Han, X., Shang, H., Kamarulzaman, A., Yamamoto, N., Pybus, O.G. and Tee, K.K. (2010) Reconstructing the Epidemic History of HIV-1 Circulating Recombinant Forms CRF07_BC and CRF08_BC in East Asia: The Relevance of Genetic Diversity and Phylodynamics for Vaccine Strategies. Vaccine, 28, B39-B44. https://doi.org/10.1016/j.vaccine.2009.07.101
|
[73]
|
Abubakar, Y.F., Meng, Z., Zhang, X. and Xu, J. (2013) Multiple Independent Introductions of HIV-1 CRF01_AE Identified in China: What Are the Implications for Prevention? PLoS One, 8, e80487. https://doi.org/10.1371/journal.pone.0080487
|
[74]
|
Seki, S., Nomura, T., Nishizawa, M., Yamamoto, H., Ishii, H., Matsuoka, S., et al. (2017) In Vivo Virulence of MHC-Adapted AIDS Virus Serially Passaged through MHC-Mismatched Hosts. PLoS Pathogens, 13, e1006638. https://doi.org/10.1371/journal.ppat.1006638
|
[75]
|
Temereanca1, A., Oprea, C., Wertheim, J.O., Ianache, I., Ceausu, E., Cernescu, C., Mehta, S.R. and Ruta, S. (2017) HIV Transmission Clusters among Injecting Drug Users in Romania. Romanian Biotechnological Letters, 22, 12307-12315.
|
[76]
|
Hassan, A.S., Pybus, O.G., Sanders, E.J., Albert, J. and Esbjörnsson, J. (2017) Defining HIV-1 Transmission Clusters Based on Sequence Data. AIDS, 31, 1211-1222. https://doi.org/10.1097/QAD.0000000000001470
|
[77]
|
Leitner, T. (2018) The Puzzle of HIV Neutral and Selective Evolution. Molecular Biology and Evolution, 35, 1355-1358. https://doi.org/10.1093/molbev/msy089
|
[78]
|
Baxter, A.E., O’Doherty, U. and Kaufmann, D.E. (2018) Beyond the Replication-Competent HIV Reservoir: Transcription and Translation-Competent Reservoirs. Retrovirology, 15, 18. https://doi.org/10.1186/s12977-018-0392-7
|
[79]
|
Rouzioux, C. and Avettand-Fenoël, V. (2018) Total HIV DNA: A Global Marker of HIV Persistence. Retrovirology, 15, 30. https://doi.org/10.1186/s12977-018-0412-7
|
[80]
|
Almodovar, S. (2014) The Complexity of HIV Persistence and Pathogenesis in the Lung Under Antiretroviral Therapy: Challenges Beyond AIDS. Viral Immunology, 27, 186-199. https://doi.org/10.1089/vim.2013.0130
|
[81]
|
Fidler, S., Stohr, W., Pace, M., Dorrell, L., Lever, A., Pett, S., Kinloch, S., Fox, J., Clarke, A., Nelson, M., et al. (On Behalf of the RIVER Trial Investigators) (2018) A Randomised Controlled Trial Comparing the Impact of Antiretroviral Therapy (ART) with a “Kick-and-Kill” Approach to ART Alone on HIV Reservoirs in Individuals with Primary HIV Infection (PHI); RIVER Trial. 22nd International AIDS Conference, Amsterdam, 2018. http://programme.aids2018.org/Abstract/Abstract/12977
|
[82]
|
UNAIDS Warns that Progress Is Slowing and Time Is Running out to Reach the 2020 HIV; Press Release Paris/Geneva, 18 July 2018. http://www.unaids.org/en/resources/presscentre/pressreleaseandstatementarchive /2018/july/miles-to-go
|
[83]
|
Rueda, S., Law, S. and Rourke, S.B. (2014) Psychosocial, Mental Health, and Behavioral Issues of Aging with HIV. Current Opinion in HIV and AIDS, 9, 325-331. https://doi.org/10.1097/COH.0000000000000071
|
[84]
|
Achterbergh, R.C.A., van der Helm, J.J., van den Brink, W. and de Vries, H.J.C. (2107) Design of a Syndemic Based Intervention to Facilitate Care for Men Who Have Sex with Men with High Risk Behaviour: The syn.bas.in Randomized Controlled Trial. BMC Infectious Diseases, 17, 398. https://doi.org/10.1186/s12879-017-2474-x
|
[85]
|
i. Article 51 of the Anti-Drug Law of China; ii. Articles 26, 27, 30 and 31 of the Regulations on the Prevention and Control of AIDS; iii. China’s Medium-and Long-term Plan for AIDS Prevention and Control (1998-2010); iv. China Action Plan for Containment and Prevention of AIDS (2006-2010). i. http://www.gov.cn/flfg/2007-12/29/content_847311.htm ii. http://www.gov.cn/flfg/2006-02/12/content_186324.htm iii. http://www.cctv.com/special/289/2/25922.html iv. http://www.gov.cn/gongbao/content/2006/content_284340.htm
|
[86]
|
Pantazis, N., Porter, K., Costagliola, D., et al. (2014) Temporal Trends in Prognostic Markers of HIV-1 Virulence and Transmissibility: An Observational Cohort Study. The Lancet, 1, E119-E126. https://doi.org/10.1016/S2352-3018(14)00002-2
|
[87]
|
Herbeck, J.T., Müller, V., Maust, B.S., Ledergerber, B., Torti, C., Di Giambenedetto, S., Gras, L., Günthard, H.F., et al. (2012) Is the Virulence of HIV Changing? A Meta-Analysis of Trends in Prognostic Markers of HIV Disease Progression and Transmission. AIDS, 26, 193-205. https://doi.org/10.1097/QAD.0b013e32834db418
|
[88]
|
Thakur, K.T., Boubour, A., Saylor, D., Das, M., Bearden, D.R. and Birbeck, G.L. (2018) Global HIV Neurology: A Comprehensive Review. AIDS, Access Ahead of Print.
|
[89]
|
Gess, M. and Forton, D. (2012) Effect of Hepatitis C Virus on the Central Nervous System of HIV-Infected Individuals. Virus Adaptation and Treatment, 4, 93-106.
|
[90]
|
Monaco, S., Mariotto, S., Ferrari, S., Calabrese, M., Zanusso, G., Gajofatto, A., Sansonno, D. and Dammacco, F. (2015) Hepatitis C Virus Associated Neurocognitive and Neuropsychiatric Disorders: Advances in 2015. World Journal of Gastroenterology, 1, 11974-11983. https://doi.org/10.3748/wjg.v21.i42.11974
|
[91]
|
CDC, Division of Cancer Prevention and Control, and Centers for Disease Control and Prevention (2018) HPV and Oropharyngeal Cancer. https://www.cdc.gov/cancer/hpv/basic_info/hpv_oropharyngeal.htm
|
[92]
|
Sonawane, K., Suk, R., Chiao, E.Y., Chhatwal, J., Qiu, P., Wilkin, T., Nyitray, A.G., Sikora, A.G. and Deshmukh, A.A. (2017) Oral Human Papillomavirus Infection: Differences in Prevalence Between Sexes and Concordance With Genital Human Papillomavirus Infection, NHANES 2011 to 2014. Annals of International Medicne, 167, 714-724. https://doi.org/10.7326/M17-1363
|
[93]
|
Carrico, A.W., Cherenack, E.M., Roach, M. E., Riley, E.D., Oni, O., Dilworth, S.E., et al. (2018) Substance-Associated Elevations in Monocyte Activation among Methamphetamine Users with Treated HIV Infection. AIDS, 32, 767-771. Ryan, B. (2018) Crystal Meth May Lead Even Well Treated HIV to Further Harm the Body. https://www.poz.com/article/crystal-meth-may-leadeven-welltreated-hiv-harm-body.
|
[94]
|
Bourque, J., Afzali, M.H. and Conrod, P.J. (2018) Association of Cannabis Use with Adolescent Psychotic Symptoms. JAMA Psychiatry, 75, 864-866. https://doi.org/10.1001/jamapsychiatry.2018.1330
|
[95]
|
Yankey, B.A., Rothenberg, R., Strasser, S., Ramsey-White, K., and Okosun, I.S. (2017) Effect of Marijuana Use on Cardiovascular and Cerebrovascular Morality. A Study using the National Health and Nutrition Examination Survey Linked Mortality File. European Journal of Preventive Cardiology, 24, 1833-1840. https://doi.org/10.1177/2047487317723212
|
[96]
|
Post, W., Haberlen, S., Zhang, L., Witt, M., Jacobson, L., Brown, T.T., et al. (2018) HIV Infection Is Associated with Progression of High Risk Coronary Plaque in the MACS. 25th Conference on Retroviruses and Opportunistic Infections (CROI 2018), Boston, abstract 77, 2018. http://www.croiconference.org/sessions/hiv-infection-associated-progression -high-risk-coronary-plaque-macs
|
[97]
|
Alvi, R.M., Neilan, A.M., Tariq, N., Awadalla, M., Afshar, M., Banerji, D., Rokicki, A., Mulligan, C., Triant, V.A., Zanni, M.V. and Neilan, T.G. (2018) Protease Inhibitors and Cardiovascular Outcomes in Patients with HIV and Heart Failure. Journal of the American College of Cardiology, 72, 518-530. https://doi.org/10.1016/j.jacc.2018.04.083
|
[98]
|
International Guidelines on HIV/AIDS and Human Rights (2006) Consolidated Version. https://www.ohchr.org/EN/Issues/HIV/Pages/InternationalGuidelines.aspx
|
[99]
|
The Basic Declaration on the Human Rights of AIDS Patients. http://www.un.org/zh/documents/treaty/files/E-CN.4-1992-82.shtml
|
[100]
|
Wang, Q.-L. and Zhang, J.-Y. (2010) Worldwide Legislative Activities to Prevent AIDS and China’s Legal Practice. Modern Law Science, 32.
|
[101]
|
Dennin, R.H. and Sinn, A. (2015) The Current HIV/AIDS Prevention Strategies—Widely Outsmarted by Omitting Realities: A Socio-Critical Analysis in the Context of Powerless Law, Ethics and Asymmetric Interpretation of Human Rights. World Journal of AIDS, 5, 275-297. https://doi.org/10.4236/wja.2015.53031
|
[102]
|
Phillips, M.D. and Schembri, G. (2015) Narratives of HIV: Measuring Understanding of HIV and the Law in HIV-Positive Patients. Journal of Family Planning and Reproductive Health Care, 42, 30-35. https://doi.org/10.1136/jfprhc-2013-100789
|
[103]
|
European Centre for Disease Prevention and Control, ECDC (2017) Evidence Brief: HIV and Laws and Policies in Europe. Monitoring Implementation of the Dublin Declaration on Partnership to Fight HIV/AIDS in Europe and Central Asia. ECDC, Stockholm.
|
[104]
|
Treskova, M., Kuhlmann, A., Bogner, J., Hower, M., Heiken, H. Stellbrink, H.J., Mahlich, J., von der Schulenburg, J.M.G. and Stoll, M. (2016) Analysis of Contemporary HIV/AIDS Health Care Costs in Germany—Driving Factors and Distribution across Antiretroviral Therapy Lines. Medicine (Baltimore), 95, e3961. https://doi.org/10.1097/MD.0000000000003961
|
[105]
|
Wang, L., Min, J.E., Zang, X., Sereda, P., Harrigan, R.P., Montaner, J.S.G. and Nosyk, B. (2017) Characterizing Human Immunodeficiency Virus Antiretroviral Therapy Interruption and Resulting Disease Progression Using Population-Level Data in British Columbia, 1996-2015. Clinically Infectious Diseases, 65, 1496-1503. https://doi.org/10.1093/cid/cix570
|
[106]
|
Bundesministerium für Gesundheit/Bundesministerium für wirtschaftliche Zusammenarbeit und Entwicklung (2016) Strategie zur Eindämmung von HIV, Hepatitis B und C und anderen sexuell übertragbaren Infektionen. BIS 2030-Bedarf-sorientiert · Integriert · Sektorübergreifend. https://www.bundesgesundheitsministerium.de/fileadmin/Dateien/5_Publikationen/ Praevention/Broschueren/Strategie_BIS_2030_HIV_HEP_STI.pdf
|
[107]
|
Kirby, T. (2018) UK Sexual Health Services Struggle with Public Health Cuts. The Lancet HIV, 5, e207-e208. https://doi.org/10.1016/S2352-3018(18)30068-7
|
[108]
|
Lin, F., Farnham, P.G., Shrestha, R.K., Mermin, J. and Sansom, S.L. (2016) Cost Effectiveness of HIV Prevention Interventions in the U.S. American Journal of Preventive Medicine, 50, 699-708. https://doi.org/10.1016/j.amepre.2016.01.011
|
[109]
|
ECDC (2017) Reversing the HIV Epidemic: Europe Needs to Scale-Up Prevention, Testing and Treatment. https://ecdc.europa.eu/en/news-events/reversing-hiv-epidemic-europe-needs-scale- prevention-testing-andtreatment
|
[110]
|
Galárraga, O., Colchero, M.A., Wamai, R.G. and Bertozzi, S.M. (2009) HIV Prevention Cost-Effectiveness: A Systematic Review. BMC Public Health, 9, S5. https://doi.org/10.1186/1471-2458-9-S1-S5
|
[111]
|
Moses, M., Haakenstad, A., Tao, T., Chapin, A. and Dieleman, J. (2018) The End of the Golden Age of HIV/AIDS Funding? Trends in HIV/AIDS Spending by Financing Source and Spending Category in 188 Countries, 2000-2015. 22nd International AIDS Conference (AIDS 2018), Amsterdam, 23-27 July 2018, Abstract TUPEE570.
|
[112]
|
Jones, D.L., Sued, O., Cecchini, D., et al. (2016) Improving Adherence to Care among “Hard to Reach” HIV Infected Patients in Argentina. AIDS and Behavior, 20, 987-997. https://doi.org/10.1007/s10461-015-1133-8
|
[113]
|
Jose, S., Delpech, V., Howarth, A., Burns, F., Hill, T., Porter, K. and Sabin, C.A. (On Behalf of the UK CHIC Study Steering Committee) (2018) A Continuum of HIV Care Describing Mortality and Loss to Follow-Up: A Longitudinal Cohort Study. Lancet HIV, 5, e301-e308. https://doi.org/10.1016/S2352-3018(18)30048-1
|
[114]
|
Mustanski, B., Parsons, J.T., Sullivan, P.S., Madkins, K., Rosenberg, E. and Swann, G. (2018) Biomedical and Behavioral Outcomes of Keep It Up! An eHealth HIV Prevention Program RCT. American Journal of Preventive Medicine, 55, 151-158. https://doi.org/10.1016/j.amepre.2018.04.026
|
[115]
|
European Centre for Disease Prevention and Control/WHO Regional Office for Europe (2017) HIV/AIDS Surveillance in Europe 2016-2017 Data. ECDC, Stockholm.
|
[116]
|
Gourlay, A., Fox, J., Gafos, M., et al. (2017) A Qualitative Study Exploring the Social and Environmental Context of Recently Acquired HIV Infection among Men Who Have Sex with Men in South-East England. BMJ Open, 7, e016494. https://doi.org/10.1136/bmjopen-2017-016494
|
[117]
|
Editorial (2013) Sex, Health, and Society: Ensuring an Integrated Response. Lancet, 382, 1757. https://doi.org/10.1016/S0140-6736(13)62532-5
|